Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0000950170-25-013891

President and CEO acquired 10,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shukla Sanjay President and CEO 2025-02-03 Option exercise +10,375 146,923 D
Derivatives
Shukla Sanjay President and CEO 2025-02-03 Option exercise · Restricted Stock Unit −10,375 10,375 D
Loading xslF345X05/ownership.xml…